Impact of gefitinib in early stage treatment on circulating cytokines and lymphocytes for patients with advanced non-small cell lung cancer

OBJECTIVES: The impact of epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitors (TKIs) on the human immune system remains undefined. This study illustrates the immunomodulatory effect of gefitinib in patients with advanced non-small cell lung cancer (NSCLC) and its relevant prognostic s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Jin, Fang, Wenfeng, Liu, Xia, Xing, Shan, Zhan, Jianhua, Ma, Yuxiang, Huang, Yan, Zhou, Ningning, Zhao, Hongyun, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328306/
https://www.ncbi.nlm.nih.gov/pubmed/28260924
http://dx.doi.org/10.2147/OTT.S112158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328306/
https://www.ncbi.nlm.nih.gov/pubmed/28260924
http://dx.doi.org/10.2147/OTT.S112158

Ejemplares similares